MediWound MDWD
NASDAQ MDWD
$13.21 +0.10 (+0.72%)
At close: Aug 21, 2026 · 4:00 PM EDT

MediWound (MDWD) Depreciation & Amortization (CF) (2013 - 2025)

MediWound (MDWD) posted quarterly Depreciation & Amortization (CF) of $418000.0 for Q3 2025, up 15.79% year-over-year from $361000.0 in Q3 2024, and up 6.09% quarter-over-quarter from $394000.0 in Q2 2025.

MediWound (MDWD) Depreciation & Amortization (CF) (2013 - 2025) Analysis & Trends

MediWound's Depreciation & Amortization (CF) history runs 13 years deep, the most recent figure standing at $418000.0 for Q3 2025.

  • In Q3 2025, Depreciation & Amortization (CF) rose 15.79% year-over-year to $418000.0; the TTM figure through Dec 2025 stood at $1.2 million (down 21.11% YoY), while the FY2024 annual figure was $1.5 million, up 13.81% from the prior year.
  • Depreciation & Amortization (CF) for Q3 2025 stood at $418000.0, up from $394000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $418000.0 in Q3 2025, with the low at $276000.0 in Q4 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $338000.0 (2022), against an average of $341000.0.
  • The sharpest annual moves came in 2021 and 2023: Depreciation & Amortization (CF) climbed 23.21% in 2021, then dropped 5.61% in 2023.
  • MediWound's Depreciation & Amortization (CF) stood at $276000.0 in 2021, then gained by 2.9% to $284000.0 in 2022, then climbed by 21.83% to $346000.0 in 2023, then advanced by 14.74% to $397000.0 in 2024, then climbed by 5.29% to $418000.0 in 2025.
  • Business Quant data shows MDWD's Depreciation & Amortization (CF) at $418000.0 in Q3 2025, $394000.0 in Q2 2025, and $358000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 40.52 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 191.83 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 MediWound 170.65 Mn 139.65 Mn 337,000.00 402,000.00

Historic Data

Download Data
DateValue
Sep 30, 2025 418,000.00
Sep 30, 2025 418,000.00
Jun 30, 2025 394,000.00
Jun 30, 2025 394,000.00
Mar 31, 2025 358,000.00
Mar 31, 2025 358,000.00
Dec 31, 2024 397,000.00
Dec 31, 2024 397,000.00
Sep 30, 2024 361,000.00
Sep 30, 2024 361,000.00
Jun 30, 2024 357,000.00
Jun 30, 2024 357,000.00
Mar 31, 2024 368,000.00
Mar 31, 2024 368,000.00
Dec 31, 2023 346,000.00
Dec 31, 2023 346,000.00
Sep 30, 2023 339,000.00
Sep 30, 2023 339,000.00
Jun 30, 2023 315,000.00
Jun 30, 2023 315,000.00